Imperative Care key facts
as of Oct 2026- Operator of a commercial-stage medical technology company intended for researching, developing, and manufacturing to improve care for people with vascular diseases.
- Imperative Care is valued at approximately $1.6B as of Oct 2026 (last reported valuation).
- It has raised $663.4M across 4 recorded rounds; the latest was Later Stage VC ($100.0M) in Mar 2026.
- Notable investors include D1 Capital Partners, Catalio Capital Management, Perceptive Advisors, Ally Bridge Group, Ascension Ventures — 20 tracked in total.
- Imperative Care has filed 6 Form Ds with the SEC since 2019, most recently Mar 2026 ($100.0M sold to 15 investors).
- Status: Privately Held (backing).
Imperative Care's last reported valuation, Jul 2024. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch Imperative Care: the Monday email on marks, rounds and moves
Imperative Care funding rounds
4 roundsWho backs Imperative Care
20+Imperative Care valuation
Imperative Care's last reported valuation was $1.6 billion in Jul 2024. No priced round, secondary trade or fund mark has surfaced since.
How much has Imperative Care raised?
Imperative Care has raised $663 million across 4 recorded rounds since 2019. The largest was an $86 million later-stage round in Nov 2019; the most recent was a $100 million later-stage round in Mar 2026.
Imperative Care has filed 6 Form Ds with the SEC since 2019, most recently in Mar 2026 ($100 million sold to 15 investors).
Imperative Care investors
20 investors are on record for Imperative Care, including D1 Capital Partners, Catalio Capital Management, Perceptive Advisors and Ally Bridge Group. By type, the record holds 5 hedge funds, 3 venture capital firms and 2 funds of funds. The later-stage round in Mar 2026 drew 15 investors.
Comparable companies
Comparable surgical devices names by valuation on PrivateMarketView: SpyGlass Pharma (NAS: SGP) ($511 million), Eximis Surgical ($18.7 million) and FEMSelect ($17 million).
About Imperative Care
Operator of a commercial-stage medical technology company intended for researching, developing, and manufacturing to improve care for people with vascular diseases. The company focuses on addressing specific gaps in treatment and care to make an impact across the entire patient journey from detection through recovery for patients with ischemic and hemorrhagic stroke and transforms thrombectomy care for people suffering from devastating vascular diseases, including pulmonary embolism, enabling healthcare providers to evolve quality practices and elevate the standard of care.
- Industry
- Surgical Devices
- Sector
- Healthcare
- HQ
- Campbell, CA, United States
- Founded
- 2015
- Employees
- 374
- Website
- imperativecare.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.